Loading...
Dernières publications
Chiffres clés
Open Access
Mots clés
Dysferlin
Myoblast
Sporadic ALS
Myopathies
DMD
Triplet expansion disease
Cell therapy
Myopathy
Skeletal muscle
Anti-fibrotic pharmacotherapies
Haploinsufficiency
Myosin
Myoblasts
Differentiation
Gene replacement
Geriatric assessment
Akt
Autoimmune diseases
Dysferlinopathy
PABPN1 agregates
Cross-bridge kinetics
Accelerometry
Transcriptomics
Aav-U7
Secreted vesicles
Omics
Exon-skipping
Arbovirus
AAV vectors
AAV
Muscle strength
Duchenne muscular dystrophy
ALS
Inflammation
FAPs
Xenograft
AChR antibodies
Muscle fibrosis
Functional genomics
Calcium
DNA methylation
Intercellular communication
Dystrophie musculaire oculopharyngée
Agrégats de PABPN1
MND
Metabolism
MUTATIONS
Alphavirus
Epigenetics
Annexin A2
Muscular dystrophy
Satellite cell
PABPN1
Andermann syndrome
Actin
Gene therapy
Atrophy
Satellite cells
Nuclear envelope
Aggregate
OPMD
APOPTOSIS
Antisens oligonucleotides
Neuromuscular disease
Muscle stem cells
Regenerative medicine
Regulatory T cells
Biomarker
ARN
Pharyngeal muscle
Muscle dystrophy
Myositis
FSHD
Anti-acetylcholine receptor antibodies
2-D PAGE
Alzheimer's disease
Dystrophin
Adipose tissue
Oculopharyngeal muscular dystrophy
Effector T cells
Amyotrophic Lateral Sclerosis
Myogenesis
Ageing
GENE
Myotube
Lamins
Antiserum
Aged
Pax7
Muscle
Human
Regeneration
Sarcopenia
Neuromuscular junction NMJ
DUX4
Thérapie génique
Mass spectrometry
RNA
Fibrosis
AUTOPHAGY